Brainstorm Cell Therapeutics Inc (BCLI NASDAQ) stock market data APIs
$0.6907
0.01(1.4%)
as of September 17, 2025
Try our APIs with
free plan!
Brainstorm Cell Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Brainstorm Cell Therapeutics Inc. a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is involved in the development of NurOwn, which has completed Phase IIIb clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for treatment of other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.
Prev. Close
0.6907
Open
0.7051
High
0.7051
Low
0.6907
52 wk Range
0.521-3.957
Market Cap
7 263 K
Shares Outstanding
10 376 K
EPS
-0.34
Beta
0.137
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Brainstorm Cell Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Brainstorm Cell Therapeutics Inc data using free add-ons & libraries
Get Brainstorm Cell Therapeutics Inc Fundamental Data
Brainstorm Cell Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -11 684 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.44
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Brainstorm Cell Therapeutics Inc News
New
Brainstorm Cell Therapeutics outlines readiness for Phase IIIb ALS trial as funding and regulatory developments shape next steps
Earnings Call Insights: Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2025 MANAGEMENT VIEW * Chaim Lebovits, President and CEO, reaffirmed that "our top priority is advancing NurOwn into our planned...
BrainStorm Cell Therapeutics GAAP EPS of -$0.77
* BrainStorm Cell Therapeutics press release [https://seekingalpha.com/pr/20200769-brainstorm-cell-therapeutics-announces-second-quarter-2025-financial-results-and-provides] (OTC:BCLI [https://seeki...
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: * JD.com (JD [https://seekingalpha.com/symbol/JD]) * Deere & Company (DE [https://seekingalpha.com/symbol/DE]) * First Majestic Silv...
BrainStorm Cell Therapeutics Q2 2025 Earnings Preview
* BrainStorm Cell Therapeutics (OTC:BCLI [https://seekingalpha.com/symbol/BCLI]) is scheduled to announce Q2 earnings results on Thursday, August 14th, before market open. * The consensus EPS Esti...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
